wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36725445-7C80672C-E408-4EF3-ADD1-7D492962F86F
Q36725445-7C80672C-E408-4EF3-ADD1-7D492962F86F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36725445-7C80672C-E408-4EF3-ADD1-7D492962F86F
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).
P2860
Q36725445-7C80672C-E408-4EF3-ADD1-7D492962F86F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36725445-7C80672C-E408-4EF3-ADD1-7D492962F86F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f742c970159114142ea69da82d5ca552eb124c98
P2860
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.